Published in Virology on October 10, 1998
Replication-defective bovine adenovirus type 3 as an expression vector. J Virol (1999) 1.12
Production of adenovirus vectors and their use as a delivery system for influenza vaccines. Expert Opin Biol Ther (2010) 1.01
Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice. BMC Infect Dis (2015) 0.80
A 72-bp internal deletion in the left inverted terminal repeat of the bovine adenovirus type 3 genome does not affect virus replication. Intervirology (2002) 0.77
Conserved arginines of bovine adenovirus-3 33K protein are important for transportin-3 mediated transport and virus replication. PLoS One (2014) 0.77
Induction of humoral responses to BHV-1 glycoprotein D expressed by HSV-1 amplicon vectors. J Vet Sci (2012) 0.75
Proteolytic Cleavage of Bovine Adenovirus 3-Encoded pVIII. J Virol (2017) 0.75
Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol (1996) 5.71
The use of fluorescein isothiocyanate in the determination of the bacterial biomass of grassland soil. Can J Microbiol (1970) 3.62
Ultrasound-assisted cannulation of the internal jugular vein. A prospective comparison to the external landmark-guided technique. Circulation (1993) 3.31
Rotavirus isolation and cultivation in the presence of trypsin. J Clin Microbiol (1977) 2.99
Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther (2000) 2.95
Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci U S A (1994) 2.21
Immunization of calves against enterotoxigenic colibacillosis by vaccinating dams with purified K99 antigen and whole cell bacterins. Infect Immun (1979) 2.06
Defense mechanisms against bovine herpesvirus: relationship of virus-host cell events to susceptibility to antibody-complement cell lysis. Infect Immun (1975) 1.98
Preliminary characterization of an epitope involved in neutralization and cell attachment that is located on the major bovine rotavirus glycoprotein. J Virol (1985) 1.97
Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J Virol (1993) 1.92
Interactions of monoclonal antibodies and bovine herpesvirus type 1 (BHV-1) glycoproteins: characterization of their biochemical and immunological properties. Virology (1984) 1.81
Proteins Specified by bovine herpesvirus 1 (infectious bovine rhinotracheitis virus). J Virol (1981) 1.80
Host responses to infectious bovine rhinotracheitis virus. III. Isolation and immunologic activities of bovine T lymphocytes. J Immunol (1974) 1.79
Randomized trial of thrombolysis versus heparin in unstable angina. Circulation (1992) 1.74
In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene. Cancer Res (2000) 1.73
Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation (1987) 1.71
Host defense mechanisms against infectious bovine rhinotracheitis virus: in vitro stimulation of sensitized lymphocytes by virus antigen. Infect Immun (1974) 1.69
Isolation and characterization of a near-haploid human cell line. Exp Cell Res (1999) 1.66
A ubiquitous mammalian expression vector, pHMG, based on a housekeeping gene promoter. Nucleic Acids Res (1989) 1.65
Protection of newborn calves against fatal multisystemic infectious bovine rhinotracheitis by feeding colostrum from vaccinated cows. Can J Vet Res (1987) 1.59
Antibody-dependent cell-mediated cytotoxicity in cows: comparison of effector cell activity against heterologous erthrocyte and herpesvirus-infected bovine target cells. Infect Immun (1976) 1.59
A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle. Vaccine (1994) 1.58
Molecular cloning, sequencing, and expression of functional bovine herpesvirus 1 glycoprotein gIV in transfected bovine cells. J Virol (1990) 1.57
Hemagglutination and hemagglutination-inhibition studies with a strain of Nebraska calf diarrhea virus (bovine rotavirus). Intervirology (1978) 1.57
Health metrics improve childhood immunisation coverage in a rural population of Andhra Pradesh. Indian J Public Health (2009) 1.55
Bovine herpesvirus-1 vaccination against experimental bovine herpesvirus-1 and Pasteurella haemolytica respiratory tract infection: onset of protection. Am J Vet Res (1982) 1.54
Comparison of rotavirus strains by hemagglutination inhibition. Can J Microbiol (1978) 1.52
Bovine herpesvirus 1 (BHV-1): biology, pathogenesis, and control. Adv Virus Res (1995) 1.52
Autonomic mechanisms in hemodynamic responses to isometric exercise. J Clin Invest (1974) 1.51
Synthesis and processing of bovine herpesvirus 1 glycoproteins. J Virol (1986) 1.51
Characterization of bovine herpesvirus 1 UL49 homolog gene and product: bovine herpesvirus 1 UL49 homolog is dispensable for virus growth. J Virol (1995) 1.48
Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension. J Heart Lung Transplant (1992) 1.45
In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. J Virol (1998) 1.45
Cardiac tamponade: hemodynamic observations in man. Circulation (1978) 1.45
Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells. J Virol (2000) 1.40
Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset. J Virol (1999) 1.40
Direct correlation of external systolic time intervals with internal indices of left ventricular function in man. Circulation (1971) 1.40
The effect of dose, route and virulence of bovine herpesvirus 1 vaccine on experimental respiratory disease in cattle. Can J Comp Med (1983) 1.39
Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease. J Virol (2002) 1.39
Respiratory sinus arrhythmia in the denervated human heart. J Appl Physiol (1985) (1989) 1.39
Bovine herpesvirus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV. J Virol (1991) 1.38
Coronary artery fistula in the heart transplant patient. A potential complication of endomyocardial biopsy. Circulation (1989) 1.37
Cloning and in vitro expression of the gene for the E3 haemagglutinin glycoprotein of bovine coronavirus. J Gen Virol (1989) 1.37
Protection of cattle from bovine herpesvirus type I (BHV-1) infection by immunization with individual viral glycoproteins. Virology (1987) 1.36
Monoclonal antibodies to bovine coronavirus: characteristics and topographical mapping of neutralizing epitopes on the E2 and E3 glycoproteins. Virology (1987) 1.35
Antigenic and immunogenic characteristics of bovine herpesvirus type-1 glycoproteins GVP 3/9 and GVP 6/11a/16, purified by immunoadsorbent chromatography. Virology (1985) 1.35
Host defense mechanisms against infectious bovine rhinotracheitis virus. II. Inhibition of viral plaque formation by immune peripheral blood lymphocytes. Cell Immunol (1975) 1.35
Mechanisms of resistant of herpesviruses: comparison of the effectiveness of different cell types in mediating antibody-dependent cell-mediated cytotoxicity. Infect Immun (1977) 1.34
Mechanisms of recovery from Herpesvirus infections -a review. Can J Comp Med (1978) 1.34
Sound pressure correlates of the second heart sound. An intracardiac sound study. Circulation (1974) 1.32
Further analysis of the role of calcium in rotavirus morphogenesis. Virology (1987) 1.32
Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Ther (1997) 1.31
Functional and topographical analyses of epitopes on bovine herpesvirus type 1 glycoprotein IV. Arch Virol (1988) 1.30
Genetic heterogeneity within individual bovine rotavirus isolates. J Virol (1982) 1.29
Mycotic keratitis. Indian J Ophthalmol (1972) 1.29
Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses. Infect Immun (1976) 1.29
The adverse effect of intravenous iron-dextran in rheumatoid arthritis. Arthritis Rheum (1969) 1.29
Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber. J Virol (1999) 1.28
The role of antibody dependent cytotoxicity in recovery from herpesvirus infections. Cell Immunol (1976) 1.27
Analysis of bovine herpes virus-type 1 isolates by restriction endonuclease fingerprinting. Arch Virol (1983) 1.26
The interaction between bovine herpesvirus type 1 and activated bovine T lymphocytes. J Gen Virol (1990) 1.25
The direct antiviral cytotoxicity by bovine lymphocytes is not restricted by genetic incompatibility of lymphocytes and target cells. J Immunol (1977) 1.24
Reactivation of temperature-sensitive and non-temperature-sensitive infectious bovine rhinotracheitis vaccine virus with dexamethasone. Infect Immun (1980) 1.23
Effect of tunicamycin on rotavirus assembly and infectivity. J Virol (1982) 1.23
Topographical analysis of bovine herpesvirus type-1 glycoproteins: use of monoclonal antibodies to identify and characterize functional epitopes. Virology (1985) 1.22
Studies on rotaviral antibody in bovine serum and lacteal secretions, using radioimmunoassay. J Am Vet Med Assoc (1978) 1.22
Comparison of the antiviral effects of 5-methoxymethyl-deoxyuridine with 5-iododeoxyuridine, cytosine arabinoside, and adenine arabinoside. Antimicrob Agents Chemother (1975) 1.21
Characterization of cell-binding properties of bovine herpesvirus 1 glycoproteins B, C, and D: identification of a dual cell-binding function of gB. J Virol (1995) 1.21
Nuclear localization of the ORF2 protein encoded by porcine circovirus type 2. Virology (2001) 1.19
An efficient procedure to select and recover recombinant adenovirus vectors. Gene Ther (1995) 1.19
CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev (2001) 1.19
Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery. J Control Release (2000) 1.18
The role of neutrophils in antiviral defense--in vitro studies on the mechanism of antiviral inhibition. J Immunol (1977) 1.18
Immune response to recombinant adenovirus in humans: capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes. J Virol (2000) 1.17
Biochemical evidence for the oligomeric arrangement of bovine rotavirus nucleocapsid protein and its possible significance in the immunogenicity of this protein. J Gen Virol (1987) 1.17
Antibody dependent cytotoxicity mediated by neutrophils: a possible mechanism of antiviral defense. J Reticuloendothel Soc (1976) 1.17
A new cellular model of response to estrogens: a bioluminescent test to characterize (anti) estrogen molecules. Biotechniques (1990) 1.17
Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. Vaccine (1993) 1.16
Molecular determinants of adenovirus serotype 5 fibre binding to its cellular receptor CAR. J Gen Virol (1999) 1.16
Bovine herpesvirus 1 UL49.5 homolog gene encodes a novel viral envelope protein that forms a disulfide-linked complex with a second virion structural protein. J Virol (1996) 1.16
Variegated gene expression in mice. Trends Genet (1997) 1.15
Viral-bacterial pneumonia in calves: effect of bovine herpesvirus-1 on immunologic functions. J Infect Dis (1985) 1.15
The mammary gland of the ox: a convenient source for the repeated collection of neutrophils and macrophages. J Reticuloendothel Soc (1976) 1.15
Expression of bovine herpesvirus 1 glycoproteins gI and gIII in transfected murine cells. J Virol (1988) 1.14
Prevention of experimental bovine pneumonic pasteurellosis with an extract of Pasteurella haemolytica. Can J Comp Med (1983) 1.14
Neutrophils in antiviral immunity: inhibition of virus replication by a mediator produced by bovine neutrophils. J Infect Dis (1980) 1.14
Quantitative, competitive PCR analysis of porcine circovirus DNA in serum from pigs with postweaning multisystemic wasting syndrome. J Clin Microbiol (2000) 1.13
The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides. J Virol (2002) 1.13
Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins. Vaccine (1990) 1.13
Chronic shedding of bovine enteric coronavirus antigen-antibody complexes by clinically normal cows. J Gen Virol (1985) 1.12
Structural proteins of bovine coronavirus and their intracellular processing. J Gen Virol (1987) 1.12
Replication-defective bovine adenovirus type 3 as an expression vector. J Virol (1999) 1.12
Antiviral screening of British Columbian medicinal plants. J Ethnopharmacol (1995) 1.12
Study of immunogenicity and virulence of bovine herpesvirus 1 mutants deficient in the UL49 homolog, UL49.5 homolog and dUTPase genes in cattle. Vaccine (1997) 1.12
Identification and deletion mutagenesis of the bovine herpesvirus 1 dUTPase gene and a gene homologous to herpes simplex virus UL49.5. Virology (1993) 1.11
Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism. Gene Ther (2001) 1.11